Anika Therapeutics (AKP.F) Q4 2024 Earnings

31OctConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.23
-0.1
0.03
0.16

Details

Expected EPS
0.08268299999999999
Actual EPS
-0.229675
Surprise EPS
-0.31
Surprise Percent
+377.78%

Description

Anika Therapeutics (AKP.F) has reported earnings of -0.229675 per share for Q4 2024.

0 Comments

Share your thoughts